Importance: Immune checkpoint inhibitors (ICIs) have yielded conflicting results in hepatocellular carcinoma (HCC). The overall effect of ICIs compared with standard therapies in unresectable HCC requires more research.
Objective: To estimate the efficacy and safety associated with ICIs compared with standard therapies in patients with unresectable HCC.
Purpose: In Brazil, a country with major health access disparities, resource limitations make management of pancreatic cancer (PC) challenging. This study evaluated curative-intent surgery for PC in the Brazilian public health care system.
Methods: We collected data for PC surgical procedures with curative intent in Brazil's public health care system (DATASUS) and from the demographic database.